The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 10, 2023
Filed:
Mar. 27, 2019
Ptc Therapeutics, Inc., South Plainfield, NJ (US);
Nadiya Sydorenko, Princeton, NJ (US);
Md Rauful Alam, Piscataway, NJ (US);
Lukiana Amedzo, Somerset, NJ (US);
Suresh Babu, Pennington, NJ (US);
Ramil Y. Baiazitov, East Brunswick, NJ (US);
Scott J. Barraza, Piscataway, NJ (US);
Anuradha Bhattacharyya, Edison, NJ (US);
Gary Mitchell Karp, Princeton Junction, NJ (US);
Nathaniel T. Kenton, Highland Park, NJ (US);
Anthony R. Mazzotti, Rahway, NJ (US);
Young-Choon Moon, Belle Mead, NJ (US);
Nicholas W. Mszar, New Brunswick, NJ (US);
Jana Narasimhan, Scotch Plains, NJ (US);
Sudipta Pal, Piscataway, NJ (US);
Jigar S. Patel, Jersey City, NJ (US);
Anthony Turpoff, Hillsborough, NJ (US);
Matthew G. Woll, Dunellen, NJ (US);
Zhenrong Xu, Chalfont, PA (US);
Nanjing Zhang, Princeton, NJ (US);
PTC THERAPEUTICS, INC., South Plainfield, NJ (US);
Abstract
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I) or Formula (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.